mRNA-4157/V940

Merck and Moderna Move Forward with Personalized Cancer Vaccine
BioSpace
Wed, 10/12/22 - 11:35 pm
Merck
Moderna Therapeutics
vaccines
mRNA-4157/V940
melanoma